We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.38B
1-Year Est. Return 63.08%
This Fund
S&P 500
This Quarter Est. Return
+16.95%
1 Year Est. Return
+63.08%
3 Year Est. Return
+180.99%
5 Year Est. Return
+483.22%
10 Year Est. Return
+2,128.62%
AUM
$1.52B
AUM Growth
-$7.28B
Cap. Flow
-$6.76B
Cap. Flow %
-444.29%
Top 10 Hldgs %
100%
Holding
929
New
Increased
6
Reduced
3
Closed
920

Sector Composition

Rank Sector Weight
1 Technology 45.54%
2 Healthcare 36.97%
3 Financials 14.43%
4 Communication Services 3.06%
5 Energy 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PIPP.WS
901
DELISTED
Pine Island Acquisition Corp. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
PIPP.WS
-175,944
Closed -$9K
IPOD
902
DELISTED
Social Capital Hedosophia Holdings Corp. IV
IPOD
-504,436
Closed -$5.05M
IPOF
903
DELISTED
Social Capital Hedosophia Holdings Corp. VI
IPOF
-405,273
Closed -$4.05M
CVET
904
DELISTED
Covetrus, Inc. Common Stock
CVET
-1,870,220
Closed -$39M
TPGY
905
DELISTED
TPG Pace Beneficial Finance Corp.
TPGY
-515,324
Closed -$5.16M
IEA
906
DELISTED
Infrastructure and Energy Alternatives, Inc. Common Stock
IEA
-46,872
Closed -$635K
ASAQ
907
DELISTED
Atlantic Avenue Acquisition Corp
ASAQ
-236,679
Closed -$2.37M
RCHGW
908
DELISTED
Recharge Acquisition Corp. Warrant
RCHGW
-237,619
Closed
AVAN
909
DELISTED
Avanti Acquisition Corp.
AVAN
-1,977,298
Closed -$19.8M
GBT
910
DELISTED
Global Blood Therapeutics, Inc.
GBT
-2,238,787
Closed -$152M
VYGG
911
DELISTED
Vy Global Growth
VYGG
-986,517
Closed -$9.89M
ASZ.WS
912
DELISTED
Austerlitz Acquisition Corporation II Warrants, each whole Warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share
ASZ.WS
-252,927
Closed -$34K
DRE
913
DELISTED
Duke Realty Corp.
DRE
-2,501,664
Closed -$121M
CHNG
914
DELISTED
Change Healthcare Inc. Common Stock
CHNG
-5,748,432
Closed -$158M
NMMC
915
DELISTED
North Mountain Merger Corp. Class A Common Stock
NMMC
-465,162
Closed -$4.67M
NLSN
916
DELISTED
Nielsen Holdings plc
NLSN
-5,474,215
Closed -$152M
DISH
917
PUT
DELISTED
DISH Network Corp.
DISH
-62,600
Closed -$1.43M
RENEU
918
DELISTED
Cartesian Growth Corporation II Unit
RENEU
-551,483
Closed -$5.52M
IVCAU
919
DELISTED
Investcorp AI Acquisition Corp. Unit
IVCAU
-459,569
Closed -$4.64M
MNTN
920
DELISTED
Everest Consolidator Acquisition Corporation
MNTN
-327,535
Closed -$3.29M
BLEU
921
DELISTED
bleuacacia ltd Class A Ordinary Shares
BLEU
-572,695
Closed -$5.65M
SEDA.WS
922
DELISTED
SDCL EDGE Acquisition Corporation Redeemable warrants, each whole warrant exercisable for one share of Class A ordinary share at an exercise price of $11.50
SEDA.WS
-73,355
Closed -$7K
FATP
923
DELISTED
Fat Projects Acquisition Corp Class A Ordinary Share
FATP
-238,623
Closed -$2.38M
BOAC.WS
924
DELISTED
Bluescape Opportunities Acquisition Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
BOAC.WS
-233,904
Closed -$26K
AAWW
925
DELISTED
Atlas Air Worldwide Holdings, Inc.
AAWW
-575,000
Closed -$55M

Similar funds

UBS O'Connor's Q4 2022 Portfolio in Review

As of Q4 2022, UBS O'Connor held 929 positions worth $1.52B, down 83% from $8.8B the previous quarter. Its ten largest holdings account for 100% of the portfolio.

UBS O'Connor withdrew a net $6.76B in Q4 2022, closing 920 positions and reducing 3 holdings. Its most notable exit was Biohaven Pharmaceutical Holding Company Ltd., an estimated $572M position sold in full.

By sector, the portfolio is most concentrated in Technology at 46% of assets, up from 28% a quarter earlier, followed by Healthcare and Financials.

Against the trend, UBS O'Connor added an estimated $184M to Horizon Therapeutics Public Limited Company Ordinary Shares.

  • UBS O'Connor added most to Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2022, an estimated $184M increase.
  • UBS O'Connor's biggest Q4 2022 reduction was Activision Blizzard, cutting an estimated $45.3M.
  • UBS O'Connor fully exited Biohaven Pharmaceutical Holding Company Ltd. in Q4 2022, selling an estimated $572M.
  • UBS O'Connor's ten largest holdings make up 100% of its $1.52B portfolio in Q4 2022.
  • UBS O'Connor opened 0 new positions and closed 920 in Q4 2022.
  • UBS O'Connor's portfolio value fell 83% quarter-over-quarter to $1.52B.

Based on UBS O'Connor's 13F filing for Q4 2022, filed 14 Feb 2023.